Hillel Grossman
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD) (NCT02033941) | Hillel Grossman | 2018-07-03 |
Track Hillel Grossman automatically
Every clearance here is in the API, with alerts when new ones post.